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Mammalian postmitotic nuclei reenter the cell cycle after serum
stimulation in newt/mouse hybrid myotubes
Cristiana P. Velloso, Andra´s Simon and Jeremy P. Brockes
Cell cycle reentry and dedifferentiation of [6]. Appendage regeneration in the newt proceeds by the
formation of a blastema, a mesenchymal growth zone ofpostmitotic cells are important aspects of the
ability of an adult newt and other urodele undifferentiated, proliferating cells that is largely derived
by local dedifferentiation of the stump tissues [1]. Afteramphibians to regenerate various tissues and
appendages [1]. In contrast to their mammalian implantation into a blastema, A1 myotubes are able both
to reenter the cell cycle and to give rise to mononucleate,counterparts, newt A1 myotubes are able to reenter
S phase after serum stimulation of a pathway leading cycling progeny cells that contribute to the blastema [9,
10]. Mammalian myotubes do not exhibit comparableto phosphorylation of the retinoblastoma protein,
pRb [2]. The activity in serum is not due to mitogenic plasticity, although reentry to S phase can be achieved
by manipulations that inactivate the Rb gene or proteingrowth factors but is generated indirectly by the
activation of thrombin and subsequent proteolysis [11–13], while the multinucleate-to-mononucleate transi-
tion can be induced by the expression of themsx-1 homeo-[3]. In this paper we describe the formation of
interspecies hybrid (heterokaryon) myotubes by the box gene or by exposure to the substituted purine called
myoseverin [14, 15].fusion of mouse C2C12 [4] and newt A1 [5, 6]
myogenic cells. The C2C12 nuclei reenter the cell
cycle upon serum stimulation of the hybrids, while Newt myotubes are induced to reenter S phase when
C2C12 homokaryon myotubes remain arrested under they are stimulated by serum from various mammalian
these conditions. These findings indicate that the sources [2]. Thus, the extracellular milieu provided by
postmitotic arrest of the mouse nuclei is undermined mammalian serum induces urodele cell cycle reentry, but
by the pathway activated in the newt cytoplasm. for some reason mouse myotubes remain in arrest. This
The hybrid myotubes provide a new model for the may be an interesting cellular model for the loss of wide-
manipulation of the postmitotic arrest in both spread regenerative ability in the mammal [3]. In order
mammalian and newt differentiated cells. to determine if mouse nuclei are able to respond to the
intracellular events induced by the serum pathway in
Address: Department of Biochemistry and Molecular Biology, newt cells, we generated interspecies hybrid myotubes.University College London, Gower Street, London WC1E 6BT,
Mononucleate C2C12 and A1 cells were mixed and cul-United Kingdom.
tured at 33C, a temperature between the optima for am-
Correspondence: Jeremy P. Brockes phibian andmammalian cells. In appropriate medium (see
E-mail: j.brockes@ucl.ac.uk Materials and methods), both precursor cells were able
to proliferate and form myotubes. After waiting 4 daysReceived: 6 March 2001
to allow fusion, we trypsinized, partially purified, andRevised: 6 April 2001
Accepted: 6 April 2001 replated the myotubes. The final preparation was a mix-
ture of mononucleate cells and myotubes, and 10%–20%
Published: 5 June 2001
of the latter were identified as hybrids in different experi-
ments. Such cultures were either maintained in mediumCurrent Biology 2001, 11:855–858
containing 0.5% foetal bovine serum (FBS) or shifted to
0960-9822/01/$ – see front matter 15% FBS for 5 days. The nucleotide analog 5-bromo-2-
 2001 Elsevier Science Ltd. All rights reserved. deoxyuridine (BrdU) was added for the last 48 hr. Cells
were fixed and processed for immunocytochemistry, and
we assayed S phase reentry by counting nuclei that had
incorporated BrdU (see Materials and methods).Results and discussion
Myogenic differentiation involves the withdrawal of mono-
nucleate precursor cells from the cell cycle and their The phase contrast image in Figure 1a shows a typical
hybrid myotube with seven nuclei. In order to distinguishfusion into multinucleate myotubes. One can achieve this
in culture by lowering the serum concentration in the the C2C12 and A1 nuclei, we used the species-specific
XB10 antibody [16], which recognizes the mouse nuclearmedium and allowing the formation of postmitotic myo-
tubes [7, 8]. Such myotubes are arrested in that they are envelope proteins lamin A and C (Figure 1b). Hybrid
myotubes were found to express myosin heavy chainrefractory to mitogens that act on their precursor cells.
Myotubes of the newt, however, have a remarkable capac- (MHC), a marker of late differentiation (Figure 1c). After
stimulation in medium containing 0.5% FBS, less thanity to reenter S phase, both in culture after serum stimula-
tion [2] and after implantation into a regenerating limb 0.6% of the homokaryon or heterokaryon myotubes con-
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Figure 1
Identification of newt/mouse hybrid myotubes. (a) Phase contrast the myotube and in the nearby mononucleate cell. (c) The MHC staining
image of a hybrid myotube lying in the vicinity of A1 (white arrowhead) in blue shows the contours of the nuclei in the syncytium. The blue
and C2C12 (white arrow) mononucleate cells. The myotube contains signal in the nearby BrdU-positive C2C12 mononucleate cell (arrow)
two mouse nuclei, which are marked with black arrows. (b) The is a result of the overlapping emission spectra of the secondary
MHC staining is in blue, and lamin staining is in red. Only the mouse antibodies used for MHC and BrdU staining. Note that the BrdU
nuclei are stained for lamin, and the A1 nuclei are negative both in incorporation result is not shown. The scale bar is 50 m.
tained BrdU-positive nuclei, while 15.3% of the mono- which only the A1 or both the A1 and C2C12 nuclei
incorporated BrdU (Figure 2d–f). It should be noted thatnucleate A1 and 94.4% of C2C12 cells were cycling (Table
1). This indicates that both classes of myotube were resis- the response of A1 homokaryon myotubes to serum was
lower at the intermediate temperature than was that ob-tant to mitogens acting on their precursor cells and hence
that the postmitotic arrest was intact. served at 25C ([2] and data not shown).
We investigated if S phase reentry of mouse nuclei inThe myotubes were purified and shifted to medium with
15%FBS.The percentage of BrdU-positiveC2C12 homo- the hybrid myotubes could be initiated by the thrombin-
derived signal that was previously found to stimulate A1karyon myotubes did not increase in high serum, whereas
the number of A1 homokaryon myotubes with BrdU- homokaryon myotubes, but not A1 mononucleate cells,
at 25C [3]. The identity of this factor is currently un-positive nuclei was elevated to 3.9%, in agreement with
earlier findings [2]. We observed that 9.8% of hybrid myo- known, but it is present in crude preparations of bovine
thrombin and has been shown to be distinct from buttubes contained C2C12 nuclei that had reentered S phase.
The BrdU-positive hybrids fell into three different cate- activated by the protease [3]. Therefore, S phase entry
was assayed in the presence of 0.5%FBS and crude throm-gories (Table 1); in most cases, only C2C12 nuclei were
labeled (Figure 2a–c), but we also found examples in bin. The A1 mononucleate cells were not responsive to
Table 1
S phase entry in myotubes and mononucleate cells.
A2 myotubes Hybrid myotubes C2C12 myotubes
Number Total Number labeled with BrdU Number Total
labeled number Percent Total number labeled number Percent
with BrdU analyzed labeled C2 only A1 only C2 and A1 analyzed with BrdU analyzed labeled
0.5% FBS 2 1083 0.2 2 (0.6%) 0 0 351 1 576 0.2
15% FBS 121 3080 3.9 43 (6.8%) 2 (0.3%) 19 (3.0%) 630 6 3635 0.2
Thrombin 8 592 1.4 18 (10.1%) 4 (2.2%) 4 (2.8%) 178 3 522 0.6
A1 mononucleate cells C2C12 mononucleate cells
0.5% FBS 52 340 15.3 240 254 94.4
15% FBS 90 279 32.3 321 324 99.1
Thrombin 52 328 15.9 198 226 87.6
This includes the cumulative data from 11 independent experiments in which we matched the response of the heterokaryon myotubes to high serum
or thrombin stimulation to control myotubes in low serum. All categories of cells were counted in the same tissue culture dishes except for the
C2C12 homokaryon myotubes, which were analyzed separately.
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Figure 2 favorable for reentry by the mammalian than by the newt
nuclei, thus curtailing the response of the A1 nuclei. The
relatively low response of the A1 homokaryons at 33C is
consistent with this hypothesis. Alternatively, the differ-
ent nuclei may reenter the cell cycle asynchronously, with
the C2C12 nuclei entering S phase first. Such a phenome-
non could be enhanced by a lower threshold for this re-
sponse in the C2C12 as compared to the A1 nuclei.
Muscle heterokaryons have proven to be informative in
the study of a variety of cellular processes [17–19]. Here
we present a newt/mouse hybrid myotubemodel in which
the corresponding homokaryons differ in their ability to
countermand the postmitotic arrest and reenter S phase.
Cell cycle reentry in A1 homokaryons is mediated by the
phosphorylation of pRb [2], and it seems plausible that
mouse nuclei in the hybrids also respond to this pathway.
In earlier experiments, mouse Rb was expressed in newt
myotubes, and acted to reinforce the arrest [2]. The re-
sponse of mammalian nuclei in the hybrids encourages
further experiments that aim to identify the newt factors
that induce cell cycle reentry. Mammalian nuclei can be
reprogrammed after transplantation to oocyte cytoplasm
[20], but the present experiments demonstrate that amore
selective aspect of plasticity can also be imposed on post-
mitotic nuclei.
Materials and methods
Generation of hybrid myotubes
A1 and C2C12 mononucleate cells were maintained as described [2].Serum stimulates the S phase entry of both A1 and C2C12 nuclei in
Cycling A1 cells were plated on 75 cm2 scored gelatin-coated dishes [2].a hybrid myotube. (a) Phase contrast image of a hybrid myotube
At 90% confluency, the amphibian medium was changed to Dulbecco’swith eight A1 and two C2C12 nuclei (arrows). (b) The MHC staining
Modified Eagle Medium (DMEM; Gibco) containing 0.5% FBS (Firstis in blue, and BrdU staining is in turquoise. The BrdU-positive
Link) at 33C, and cells were grown in the presence of 10% CO2. AfterC2C12 nucleus is marked with an arrow. (c) The MHC staining is in
1 day, C2C12 cells were added to the A1 cells at a 4:1 A1:C2C12blue, and lamin staining is in red. The C2C12 nuclei are lamin-
ratio. After 4 days of fusion, the hybrids were purified as described forpositive and one has incorporated BrdU, while none of the A1 nuclei
A1 homokaryons [2] and plated on fibronectin-coated dishes.have labeled. (d) Phase contrast image of a hybrid myotube with
two A1 (arrowheads) and two C2C12 nuclei (arrows). (e) The MHC
staining is in blue, and BrdU staining is in turquoise. The A1 nuclei S phase reentry assay
are marked with arrowheads, and C2C12 nuclei are marked with The purified myotubes were cultured in DMEM containing 0.5% FBS or
arrows. (f) The MHC staining is in blue, and lamin staining is in red. shifted either to DMEM containing 15% FBS or to DMEM containing
Both lamin-positive C2C12 nuclei have incorporated BrdU. The weak, 0.5% FBS and 100 g ml1 crude thrombin (Calbiochem) [3]. After 3
punctate labeling in the A1 nuclei that we occasionally observed is days, BrdU was added to a final concentration of 10 mM. After 5 days,
probably due to the transfer of the mouse antigen between the two cells were washed once in PBS and fixed in 2% paraformaldehyde in
types of nuclei. The scale bar is 50 m. PBS for 20 s, then postfixed in 100% ice-cold methanol for 5 min.
Immunocytochemistry and image analysis
BrdU and MHC staining were performed as described [2]. BrdU staining
was visualized with a fluorescein-conjugated IgG1-specific secondarycrude thrombin as expected [3], but 1.4% of the A1 homo-
antibody (Southern Biotechnology Associates), and MHC staining waskaryon myotubes were induced to reenter the cell cycle.
visualized with a biotin-conjugated secondary antibody (Dako) and cas-
Importantly, in 12.9% of the hybrid myotubes the C2C12 cade blue-conjugated streptavidin (Molecular Probes). To visualize lamin-
nuclei reentered S phase, either exclusively or in conjunc- staining by the XB10 antibody, we used IgM-specific, texas red-conju-
gated secondary antibody (Southern Biotechnology Associates). Cellstion with A1 nuclei (Table 1). These experiments indicate
were observed under a Zeiss Axiophot 2 microscope. Images werethat postmitotic mouse C2C12 nuclei were responsive to
captured on a color CCD camera (Japanese Video Company) and were
activation of the newt pathway in the interspecies hetero- color-corrected with Image-Pro-Plus software (Media Cybernetics).
karyons.
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